de-la-Calva-Ceinos, Carolina; DENO-Res-Grp, Manuel; Angulo, Manuel; González-Rojo, Paula; Peiró, Ana; Machado, Pau; Cebrian, Juan-Luis; García-Maroto, Roberto; Valcárcel, Antonio; Puertas, Pablo; Valero-Cifuentes, Gregorio; Pablos, Oscar; Maireles, Miriam; Fontalva, María-Luisa; Chaves, Iván; Orce, Aida; Coll-Mesa, Luis; Pérez, Israel; González, Fausto; del-Carmen-Sanz, María; Gracia, Isidro
(WILEY, 2025-01)
BACKGROUND: Denosumab represents a valuable treatment option for unresectable giant cell tumors of the bone (GCTBs). However, no standardized protocols exist determining the length of administration, with few studies having ...